• Muhammad Tayyab
  • Muhammad Saeed Anwar
  • Inam Qadir Javed Hashmi


Poliomyelitis presents as acute febrile illness withsudden onset of weakness of extremities. It is causedby type 1,2, and 3 poliovirus and spreads mostcommonly by faecal-oral route, particularly in areaswith poor sanitation.1'2 It is primarily a disease ofchildren, 70-90% of the cases occur in those less than3 years of age. 3 The disease is preventable throughimproved sanitation, hygiene and immunization withpolio vaccines.In May 1988, World Health Assembly (WHA)declared that World Health Organization (WHO) wascommitted to the global eradication of poliomyelitisby the year 2000.4 Substantial progress towards theglobal eradication of poliomyelitis by the year 2000has been achieved since May 1988. Today the worldstands on the brink of achievement of goal of globalpoliomyelitis eradication, under the leadership ofWHO


Bodian D, Horstmann DM. Poliovirus. In: Horsfall FL

Jr, Tamm I. Eds. Viral and Reckettsial Infection of

Man. 4th Ed. Philadelphia: JB Lippincott Company,

; 430-73.

Shandera S, Gill F.P, Infectious diseases: Viral and

Reckettsial. In: Lawemce M, Tierney JR, Stephen J,

McPhee Maxine. VP, eds. Current Medical Diagnosis

and 'treatment. 33rd Ed. Norwalk: Appleton and Lange,

: 1096-1128.

Hull HF, Ward NA, Hull BP, Milstein JB, deQuadros

C, Paralytic poliomyelitis: Seasoned strategies,

disappearing disease. Lancet 1994; 343: 1331-37.

WHO. Expanded programme on immunization (EPI):

Reported trends of EPI disease in Europe. Weekly

Epidemiol Rec 1988; 63:81-84.

Tangermann RH, Aylward P, Birmingham M, et al.

Current status of the global eradication of

poliomyelitis. World Health Statis Quart 1997; 50: 188-

Nakajima II. World Health Day 1995. Target 200-A

world without polio. World Health 1995; 1:3.

CDC. Progress towards global eradication of

poliomyelitis, 1988-1993. MMWR 1994; 43(27): 499-

Lodhi ZH. National polio immunization day 1994

Pakistan report. Fed EPl Cell NH 1994:1.

Could T. But the malady lingers on - Summer plague.

Reviews Angier Carol J Spectator 1995; 274: 39.

Garrison FH, ed. History of Medicine. 4Ul Ed. London:

WB Saunders Company, 1960: 638.

Melnick JL. Enteroviruses. In: Evans AS, ed Viral

Infections of Humans, Epidemiology and Control. New

York: Plenum Medical Book Company, 1976; 163-207.

WH O Tech Report Series. Expert Committee on

Poliomyelitis. First Report.

Gamble DR. Enteroviruses; polio, echo, and coxsackie

virus. In: Wilson G, Miles A, Parker MT, eds. Topley

and Wilson’s Principles of Bacteriology, Virology and

Immunity. 7dl Ed. 19X4: 4:1342.

Anonymous. Epidemic on otterereck. 1994; 58(7): 122.

Anonymous. End of the road for poliomyelitis? Nature

; 374: 663. Anonymous. Destruction of small pox

virus by 1999. UN Chronicle 1996; 33(2):79.

Silverstein AM, ed. A History of Immunology. New

York Academic Press. Inc. 1989; 107.

Minor PD, Bell EJ. Pieomaviridae (excluding

rhinovirus). In: Collier LH, Tibmury MC. eds. Topley

and Wilson’s Principles of Bacteriology, Virology and

Imminity. 7'1' Ed. London: Edward Arnold 1990: 324-

White DO. Fenner F. eds. Medical Virology. 3ld Ed.

New York Academic Press, 1986: 451-78.

Henderson RH. The WHO plan of action for global

eradication of poliomyelitis by the year 2000. Ann NY

acad Sci 1989; 509: 69-85.

Hull FH, Aylward RB. Ending polio immunization.

Science 1997; 277: 780.

Horstman DM. Control of poliomyelitis. A continuing

paradox. J Infect Dis 1982: 146:504-51.

WHO. Poliomyelitis in 1985. Part I and 2. Weekly

Epidemiol Rec 1987: 62:273-82.

WHO Geographical distribution of poliomyelitis cases.

Week Epid Record 1995; 70(14): 100-101.

WHO. Expanded programme on immunization (EPI).

Progress towards poliomyelitis eradication, 1995.

Week Epidemiol Recc 1996; 71:189-96,253-260.

Stanway G, Cann AJ, Hauptmann R, et al. The

nucleotide sequence of poliovirus type 31eon 12 AB:

Comparison with poliovirus type 1. Nucleic Acids Res

; 11(16):5629-43.

Bums SM, Ignlis JM. Picornaviruses. In: Greenwood

D, Slack

RCB. Peutherer .IE, eds. Medical Microbiology; A

guide to Microbial Infections: Pathogenesis Immunity,


JAMC, Vol. 12, 2, 2000

Diagnosis and Control. 14th Ed. London: Churchill

Livingstone. 1992; 549-54.

Minor PD, Ferguson M, Evans DMA, Almond JW,

Icenogle JP. Antigenic structure of polioviruses of

serotypes 1,2 and 3. J Gen Virol 1986; 67:12X3-91.

Rueckert RR. Picornaviridae and their replication. In:

Fields BN, Knipe DM. Virology. 2"d Ed. New York:

Raven Press Ltd., 1990: 507-48.

Melnick JL. Enteroviruses: Polioviruses,

coxsackieviruses, echoviruses and new enteroviruses.

In: Field BN, Knipe DM. et al. Virology. 2nd Ed. New

York: Raven Press, 1990: 549-605.

Putnak JR, Phillips BA. Picornaviral structure and

assembly. Microbiol Rev 1981; 45:287-315.

Yogo Y, Wimmer FI Polyadenylic acid at the 3’

terminus of poliovirus RNA. Proc Nat Acad Sci (USA)

; 69: 1877-82.

Meissner C. Polio and other enteroviruses. In:

Schachter M, Med off G, Schlesinger D, eds.

Mechanism of Microbial Disease. London: Williams

and Wilkins 1989: 462-70.

Pelletier J, Sonenberg N. Nature 1988: 334-320.

WHO. Manual for the virological investigation of

poliomyelitis. “Poliomyelitis eradication by the year

” EPI/Polio 1990: 32-80.

Sabin AB. Pathogenesis of poliomyelitis: Reappraisal

in the light of new data. Science 1956; 123:1151-57.

Howe HA, Wilson JL. Poliomyelitis. In: River TM,

Horsfall FL Jr, eds. Viral and Rickettsial Infection of

Man. 3rd Fid. Philadelphia: JB Lippincott Company,

; 432-79.

Eichner M, Dietz K. Eradication of poliomyelitis:

When can one be sure that poliovirus transmission has

been terminated. AmJ Epidemiol 1996; 143(8):816-22.

Ogra PL. Mucosal immune response to poliovirus

vaccines in childhood. Rev Infect Dis 1984; 6(Suppl 2):


Paul JR, Riordan JT, Melnick JL. Antibodies to three

different antigenic types of poliomyelitis virus in sea

from North Al- Askan Eskimos. Am J Hyg


Hull HE. Lee JW. Sabin, Salk or sequential? Lancet

; 347:630.

Schouh BD, Johnson S, Mcannervey JM, Kustner

PIGV, Merwe CAVD. A comprehensive investigation

of immunity to poliomyelitis in a developing country.

Am J Epidemiol 1986; 123:316-24.

Simmons A. Marmion BP. Laboratory diagnosis of

virus injections. In: Collee JG, Marmion BP. Fraser

AG, Simmons. A eds. Practical Medical Microbiology.

th Ed. New York: Churchill Livingstone, 1996; 637-

Melnick JL, Wenner HA, Philips CA. Enteroviruses.

In: Lennette EH, Schmidt NJ, eds. Diagnostic

Procedures for Viral, Reckettsial and Chlamydial

Injections. 51*1 Ed. Washington DC: American Public

Health Association, 1979; 471-534.

Lamb G.A Plexico K. Glezen WP, Chin TDY. Use of

microtechnique for serum neutralization and vims

identification. Public Health Rep 1965: 80(5):463-66.

Melnick JL. Enterovirus type 71 infections: A varied

clinical pattern sometimes mimicking paralytic

poliomyelitis. Review Infect Dis 1984; 6:387-90.

Jawetz E, Melnick JL., Adelberg EA (eds). Review of

Medical Microbiology. California: Appleton and Lange

: 432-6.

Ghendon Y, Robertson SE. Interrupting the

transmission of wild polioviruses with vaccines

immunological consideration. Bull WHO 1994;


Msambichaka KA. The role of women. World Health

; 1:28.

Wright PF, Kim-Farley RJ, deQuadros CA et al.

Strategies for the global eradication of poliomyelitis by

the year 2000. N Engl J Mel 1991; 325: 1994-79.

Banerjee C, Horstmann DM. Poliovirus. In: Horsfall

FL Jr, Tamm I, eds. Viral and Rickettsial Infection of

Man. 4* Ed, Philadelphia: JB Lippincott Company,

; 430-73.

Melnick JL. Advantages and disadvantages of killed

and live poliomyelitis vaccines. Bull WIIO 1978;


Salk J, Salk D. Control of influenza and poliomyelitis

with killed vims vaccines. Science 1977; 195:834-46.

McBean Am, Thomas ML, Johnson RH. et al. A

comparison of the serologic responses to oral and

injectable trivalent poliovirus vaccines. Rev Infect Dis

; 6(Suppl 2): S552- S55.

Onorato IM, Modlin JF. McBean AM, Thomas ML,

Losonsky GA Bernier RFI. Mucsoal immunity induced

by enhanced- potency inactivated andoral polio

vaccines. J Infect Dis 1991; 163:1-6.

Sutter RW, Patriarca PA Brogan S, et al. Outbreak of

paralytic poliomyelitis in Oman: Evidence for

widespread transmission among fully vaccinated

children. Lancet 1991; 338:715-20.

Andrus JK, Strebel PM, deQuadros C, Olive JM. Risk

of vaccine-associated paralytic poliomyelitis in Latin

America 1989-91. Bull WHO 1995; 73(l):33-40.

Almond JW, Stanway G, Cann AJ, et al. New

poliovirus vaccines a molecular approach vaccine

; 2:177-84.

Svitkin YV, Maslova Sv, Agol VI. The genomes of

attenuated and virulent poliovirus strains differ in them

in vitro translation efficiencies. Virology 1985;


Hashmi IQJ, Tayyab M, Ditta A Asghar H. A

virological study of suspected cases of poliomyelitis

(Under publication). Pak Postgraduate Med J, 1998

Most read articles by the same author(s)